How do Perceptions of Coronavirus Disease (COVID-19) Risk Influence Health Decisions in Pregnancy?

Sponsor
McMaster University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05663762
Collaborator
University of British Columbia (Other), Canadian Institutes of Health Research (CIHR) (Other)
270,000
2
20
135000
6736.2

Study Details

Study Description

Brief Summary

Pregnant people have a higher risk of severe COVID-19 disease. Pregnant people have been disproportionately impacted by COVID-19 infection control policies, which have resulted in higher rates of intimate partner violence, mental health distress, employment and income loss. This project examines the impact of accumulated individual health decisions, describing how perinatal healthcare use and outcomes changed during the COVID-19 pandemic.

Objectives, questions and hypotheses

This research study has two objectives:
  1. Describe differences between Pre-Pandemic (05/01/2019-12/01/2019 births), Early-Pandemic (05/01/2020-12/01/2020 births), and Late-Pandemic (05/01/2021-12/01/2021 births) pregnancy cohorts in Ontario and British Columbia relative to key outcomes and quality of care indicators related to vaccination, perinatal care, and mental health. Examine the differential impacts on racialized and low-income pregnant people. (Quantitative strand)

  2. Understand how pregnant people's perceptions of COVID-19 risk and pandemic circumstances influenced their decision-making about key elements of pregnancy, including vaccination, perinatal care, social support and mental health. (Qualitative strand)

Research questions and hypotheses have been operationalized according to our three themes:

Theme 1: Vaccination Theme 2: Perinatal Care Theme 3: Mental Health and Social Support

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This project examines individual health decisions that occur within these structural environments, describing their accumulated impact on key pregnancy outcomes and care indicators related to three themes: vaccination, perinatal care, social supports and mental health. The decisions made during pregnancy have longitudinal impacts on the life of the pregnant person, future child, and family.(1) Given evidence of the particularly difficult situations faced by pregnant people, and the importance of these health decisions, it is important to understand how pandemic circumstances have shaped health decision-making. Understanding how and why pregnant people are making health decisions allows for better clinical and social support as the pandemic endures, and will inform future policy planning. This project is a cross-provincial, parallel mixed-methods study, with thematic data integration at the design and interpretation stages. Ontario and British Columbia were chosen as the two provinces of study because they both experienced a significant impact from COVID-19, both have access to comprehensive administrative health data, and a large number of live births each year.

    This study was funded in late February 2022. The quantitative cohort creation plans and data access requests were finalized in late Fall 2022. Qualitative data collection was piloted in Summer 2022 and preliminary data from a small sample of Ontario participants was collected in Fall 2022. Qualitative data collection in both provinces is currently (December 2022) ongoing. Study completion is anticipated for February 2024.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    270000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    How do Perceptions of Coronavirus Disease (COVID-19) Risk Influence Health Decisions in Pregnancy?
    Actual Study Start Date :
    Jun 1, 2022
    Anticipated Primary Completion Date :
    Jan 1, 2024
    Anticipated Study Completion Date :
    Feb 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Pre-pandemic births

    Live hospital births that occurred May 1 - December 1 2019

    Early- pandemic births

    Live hospital births that occurred May 1 - December 1 2020

    Late- pandemic births

    Live hospital births that occurred May 1 - December 1 2021

    Outcome Measures

    Primary Outcome Measures

    1. Vaccination [Specified groups from May 1 2019 - December 1 2021]

      Were rates of vaccination different between Pre, Early, and Late pandemic groups? Outcomes: Tdap (Ontario only) and COVID-19 vaccination rates

    2. Perinatal Care [Specified groups from May 1 2019 - December 1 2021]

      Were rates of in-person perinatal care different between Pre, Early, and Late pandemic groups? Outcomes: Gestational diabetes screening, post-partum length of stay

    3. Mental Health and Social Support [Specified groups from May 1 2019 - December 1 2021]

      Were the rates of clinical diagnosis for new depression, anxiety, and adjustment disorders during pregnancy different between Pre, Early, and Late pandemic groups?

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • live, in-hospital birth during the investigators' timeframes of interest

    • valid birth date or death date in administrative records

    • be of female sex

    • been eligible for Ontario Health Insurance Plan in Ontario or Medical Services Plan in British Columbia for the entirety of their pregnancy period

    Exclusion Criteria:
    • birth outside of a hospital

    • stillbirth

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of British Columbia Vancouver British Columbia Canada V6T 1Z4
    2 McMaster University Hamilton Ontario Canada L8P1H6

    Sponsors and Collaborators

    • McMaster University
    • University of British Columbia
    • Canadian Institutes of Health Research (CIHR)

    Investigators

    • Principal Investigator: Meredith Vanstone, PhD, McMaster University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    McMaster University
    ClinicalTrials.gov Identifier:
    NCT05663762
    Other Study ID Numbers:
    • CovPreg2022
    First Posted:
    Dec 23, 2022
    Last Update Posted:
    Jan 11, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by McMaster University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 11, 2023